Indian pricing body initiates action to check essential meds shortage

India's apex pricing authority has swung into action to tackle the ''scarcity'' of certain essential medicines including an antimalarial combination and rabies vaccines setting sharp compliance timelines for industry. Pharmaceutical firms, meanwhile, claim the current situation is a result of the government's own lopsided pricing policy.